Page last updated: 2024-08-25

zoledronic acid and Milk-Alkali Syndrome

zoledronic acid has been researched along with Milk-Alkali Syndrome in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (5.56)	18.2507
2000's	47 (43.52)	29.6817
2010's	42 (38.89)	24.3611
2020's	13 (12.04)	2.80

Authors

Authors	Studies
Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L	1
Chakhtoura, M; El-Hajj Fuleihan, G	1
Berns, JS; Geara, AS; Shulman, R	1
Çakır, Ö; Çizmecioğlu-Jones, FM; Demirsoy, U; Jones, JH; Kilci, F	1
Shane, E; Walker, MD	1
Lopes, MG; McNaught, KA; Morris, JS; Tosi, G	1
Bassatne, A; Drake, MT; El-Hajj Fuleihan, G; Murad, MH; Piggott, T; Rahme, M	1
Carsen, S; Feber, J; Khan, N; Konji, VN; Koujok, K; Molina, MO; Page, M; Rauch, F; Robinson, ME; Seale, E; Sheffield, H; Smit, K; Walker, S; Ward, LM	1
Faiq, S; Hu, T; Ku, G; Lavelle, K; Shoback, D	1
Cao, S; Jin, J; Luo, Y; Shan, X; Wu, H; Wu, Y; Zheng, Z	1
Kushima, C; Nakazato, M; Uchida, T; Yamaguchi, H; Yonekawa, T	1
Elazzazy, S; Hamad, A; Nasser, SM; Sahal, A	1
Colak, U; Hatun, S; Kayserili, H; Mutlu, GY; Sozmen, BO; Yucel, EB	1
Alvarado, M; Bueno, S; González, L; Ramírez, M; Sierra, M	1
Ntanasis-Stathopoulos, I; Terpos, E	1
Ebata, T; Ishiwata, T; Iwasawa, S; Saito, G; Takiguchi, Y; Tatsumi, K; Yoshino, I	1
Eltze, E; Zimmer, V	1
Bansal, B; Farooqui, KJ; Kuchay, MS; Mishra, SK; Mithal, A; Sekhar, L	1
Arase, H; Eriguchi, M; Fujisaki, K; Kitazono, T; Nakamura, M; Nakano, T; Okabe, Y; Tachibana, S; Tomita, K; Tsuruya, K; Yamada, S	1
Peña, S	1
Finazzo, F; Manzoni, P; Militello, MA; Re, MP; Vitaliti, G; Vitaliti, SM	1
Lightowlers, S; Patterson, D	1
Efthymiadou, A; Gkentzi, D; Karana-Ginopoulou, A; Kolyva, S; Varvarigou, A	1
Açıkgöz, Y; Aksoy, S; Ozdemir, NY; Sendur, MA; Uncu, D; Zengin, N	1
Kumar, G; Kumar, N; Sundriyal, D; Walia, M	1
Bezaury, AP; Nevarez-Barragan, MJ; Perez-Diaz, I; Rosas-Jurado, MG; Trejo-Rosales, R	1
Addissie, B; Kumar, R; Martens, P	1
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C	1
Body, JJ; Braun, A; Diel, IJ; Feng, A; Goldwasser, F; Spencer, A; Steger, G; Stopeck, AT; Vadhan-Raj, S; von Moos, R	1
Ananth, CV; Burke, WM; Chen, L; Hershman, DL; Hou, JY; Neugut, AI; Richards, CA; Tergas, AI; Wright, JD	1
Cheung, MS	1
George, S; Hummel, K; Kaplan, P; Levine, MA; Monk, HM; Weber, DR	1
Agarwal, A; Aung, TT; Strand, AO	1
Clark, SL; Nystrom, EM	1
Chang, B; Du, SX; Hu, QX; Li, XD; Lin, FX; Xie, D; Yu, GY; Zheng, GZ	1
Ato, M; Iwagami, M; Kano, S; Ota, N; Seki, T; Yamamoto, K	1
Agosto, S; Ahmadi, S; Bruder, JM; Koops, M; Toro-Tobón, D	1
Carcas, AJ; Cordoba, R; Hernandez-Navarro, F; Lei, SH; Lopez de la Guia, A; Ramirez, E; Sanjurjo, MJ	1
Linneman, T; McMahan, J	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
Ericson, S; Gruia, G; Hohneker, J	1
Habib, EE; Sabry, NA	1
Boutrus, R; El-Attar, I; El-Hossieny, H; Kader, YA; Nazmy, M; Zaghloul, MS	1
Civantos Modino, S; Díaz Guardiola, P; Guijarro de Armas, MG; Montaño Martínez, JM; Pavón de Paz, I; Zubieta Tabernero, J	1
Fujikawa, Y; Kadoya, S; Matsumoto, Y; Murakami, N; Murasugi, K; Ohura, F; Tanabe, K; Yoshii, I	1
Argüelles Jiménez, I; Carrillo García, P; García Fernández, H; Quevedo Juanals, J; Serra Soler, G	1
Chiu, CF; Lin, PH; Lu, YS	1
Aksoy, S; Arık, Z; Ozdemir, NY; Sendur, MA; Uncu, D; Yaman, S; Zengin, N	1
Ludwig, H; Zojer, N	1
Imamura, F; Sakai, D; Sugimoto, N; Yagi, T; Yoshinami, T	1
Botteman, MF; Carter, JA; Joshi, AD; Kaura, S	1
Bensimon, AG; Ericson, SG; Guo, A; Marynchenko, M; Namjoshi, M; Raje, N; Wu, EQ; Yu, AP	1
Legrand, SB	1
Avgoustidis, N; Ioakeimidis, D; Karageorgas, TP	1
Henk, HJ; Kaura, S	1
Boikos, SA; Hammers, HJ	1
Tao, H; Wang, M; Wang, Y; Wang, Z; Yu, X	1
Hassali, MA; Hassan, BA; Othman, SB; Weiderpass, E; Yusoff, ZB	1
Edwards, S; Laing, K; McCarthy, J; McCrate, F; Murphy, L; Powell, E; Seal, M	1
Major, P	1
Goa, KL; Wellington, K	1
Cook, R; Major, PP	1
Berenson, JR	2
Ashcroft, AJ; Davies, FE; Morgan, GJ	1
Bigos, ST	1
Coleman, RE; Neville-Webbe, Hl	1
Davis, LE; Li, EC	1
Body, JJ	3
Fraser, WD; Mishra, V; Peter, R	1
Bartsch, R; Hussian, D; Locker, GJ; Pluschnig, U; Sevelda, U; Steger, GG; Wenzel, C; Zielinski, CC	1
Figgitt, DP; Perry, CM	1
Berenson, J; Hirschberg, R	1
Breay, S	1
Bergner, R; Diel, IJ	1
Inoue, K; Kawada, K; Minami, H; Okabe, K; Sasaki, T; Sawamura, M; Takashima, S; Watanabe, T; Yagi, Y	1
Khuri, F; Saba, N	1
Rexer, H	1
Barone, A; Foppiani, L; Palummeri, E; Prete, C; Senesi, B; Trasciatti, S; Veneziano, M	1
Balla, J	1
Lugassy, G	1
Etayo-Pérez, A; Garatea-Crelgo, J; Martino-Gorbea, R; Pastor-Zuazaga, D; Sebastián-López, C	1
Suzuki, M; Tomoo, T	1
Bian, SG; Jiang, ZF; Shen, G; Song, ST; Wang, JJ; Wang, YJ; Xie, GR	1
Inoue, K; Iwase, H; Kawazoe, T; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yamamoto, Y; Yoshida, Y	1
Chen, NL; Diaz-Borjon, A; Lim, SS; Seyler, TM	1
Bandeira, F; Colares, V; Griz, L	1
Sakurai, T	1
Barlogie, B; Elici, F; Gokden, N; Kumar, J; Zangari, M	1
Armstrong, A; Branstetter, D; Bussiere, J; Cowan, L; Dougall, WC; Jones, J; Kennedy, B; Miller, RE	1
Maxwell, C	1
Isaia, GC; Pellissetto, C; Ravazzoli, M; Tamone, C	1
Green, JR; Jaeggi, KA; Müller, K	1
Delmas, PD; Lipton, A	1
Delmas, PD	1
Green, J	1
Body, JJ; Ford, J; Lortholary, A; Romieu, G; Vigneron, AM	1
Coleman, RE	1
Abdi, E; Bell, R; Body, J; Hon, J; Lortholary, A; Major, P; Menssen, HD; Mills, G; Quebe-Fehling, E; Seaman, J; Yunus, F	1
Coleman, RE; Major, PP	1
Cheer, SM; Noble, S	1
Lortholary, A	1
Schwetz, BA	1
Davidson, TG	1
Heatley, S	1

Reviews

37 review(s) available for zoledronic acid and Milk-Alkali Syndrome

Article	Year
Treatment of Hypercalcemia of Malignancy. Endocrinology and metabolism clinics of North America, 2021, Volume: 50, Issue:4 Topics: Bone Density Conservation Agents; Denosumab; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Zoledronic Acid	2021
Hypercalcemia: A Review. JAMA, 2022, 10-25, Volume: 328, Issue:16 Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Immune Checkpoint Inhibitors; Nausea; Neoplasms; Pamidronate; Parathyroid Hormone; SARS-CoV-2; Sleepiness; Sodium Chloride Symporter Inhibitors; Vitamin A; Vitamin D; Vomiting; Zoledronic Acid	2022
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study. The Journal of clinical endocrinology and metabolism, 2023, 02-15, Volume: 108, Issue:3 Topics: Adult; Cross-Sectional Studies; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Quality of Life; Zoledronic Acid	2023
Controversies in the use of new bone-modifying therapies in multiple myeloma. British journal of haematology, 2021, Volume: 193, Issue:6 Topics: Bone Density Conservation Agents; COVID-19; Denosumab; Diphosphonates; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Receptor Activator of Nuclear Factor-kappa B; Renal Insufficiency; Zoledronic Acid	2021
Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature. Journal of pediatric endocrinology & metabolism : JPEM, 2014, Volume: 27, Issue:3-4 Topics: Bone Density Conservation Agents; Bone Neoplasms; Child; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Zoledronic Acid	2014
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. BMC endocrine disorders, 2015, Jan-28, Volume: 15 Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid	2015
Drugs Used in Paediatric Bone and Calcium Disorders. Endocrine development, 2015, Volume: 28 Topics: Acetazolamide; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Calcitriol; Calcium; Child; Denosumab; Diphosphonates; Diuretics; Glucocorticoids; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Osteoporosis; Parathyroid Hormone; Phosphates; Risedronic Acid; Sodium Potassium Chloride Symporter Inhibitors; Vitamin D; Zoledronic Acid	2015
Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. European journal of cancer care, 2017, Volume: 26, Issue:6 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Orthopedic Procedures; Prostatic Neoplasms; Radiotherapy; Spinal Cord Compression; Zoledronic Acid	2017
Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review. The American journal of case reports, 2017, Feb-27, Volume: 18 Topics: Blast Crisis; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Zoledronic Acid	2017
Supportive therapy in multiple myeloma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2011, Volume: 183 Topics: Anemia; Blood Transfusion; Bone Diseases; Calcitonin; Clodronic Acid; Diphosphonates; Erythropoietin; Fractures, Bone; Hematinics; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteoporosis; Pamidronate; Recombinant Proteins; Renal Insufficiency; Zoledronic Acid	2011
Modern management of malignant hypercalcemia. The American journal of hospice & palliative care, 2011, Volume: 28, Issue:7 Topics: Bone Density Conservation Agents; Calcitonin; Clinical Protocols; Diphosphonates; Fluid Therapy; Gallium; Humans; Hypercalcemia; Imidazoles; Neoplasms; Palliative Care; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid	2011
Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature. Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5 Topics: Adult; Antibodies, Antinuclear; Bone Density Conservation Agents; Diphosphonates; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Imidazoles; Lupus Erythematosus, Systemic; Zoledronic Acid	2011
The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy. The oncologist, 2002, Volume: 7, Issue:6 Topics: Anti-Inflammatory Agents; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid	2002
Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs, 2003, Volume: 63, Issue:4 Topics: Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Drug Administration Schedule; Humans; Hypercalcemia; Imidazoles; Kidney; Zoledronic Acid	2003
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2002
Treatment of hypercalcemia of malignancy with bisphosphonates. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 21 Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2002
Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. The Lancet. Oncology, 2003, Volume: 4, Issue:5 Topics: Antineoplastic Agents; Bone and Bones; Bone Density; Bone Neoplasms; Chemokines; Clinical Trials as Topic; Clodronic Acid; Cytokines; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteolysis; Patient Selection; Treatment Outcome; Zoledronic Acid	2003
Selected therapy-related clinical research topics in osteoporosis. Journal of pediatric endocrinology & metabolism : JPEM, 2003, Volume: 16 Suppl 3 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Female; Hip Fractures; Humans; Hypercalcemia; Imidazoles; Injections; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Osteoporosis; Zoledronic Acid	2003
The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia. Palliative medicine, 2003, Volume: 17, Issue:6 Topics: Bone Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Matrix Metalloproteinases; Randomized Controlled Trials as Topic; Zoledronic Acid	2003
Zoledronic acid: a new parenteral bisphosphonate. Clinical therapeutics, 2003, Volume: 25, Issue:11 Topics: Animals; Bone Diseases, Metabolic; Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Half-Life; Humans; Hypercalcemia; Imidazoles; Metabolic Clearance Rate; Neoplasms; Zoledronic Acid	2003
Hypercalcemia of malignancy. Seminars in nephrology, 2004, Volume: 24, Issue:1 Topics: Antineoplastic Agents; Diphosphonates; Forecasting; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid	2004
Zoledronic acid: a review of its use in patients with advanced cancer. Drugs, 2004, Volume: 64, Issue:11 Topics: Area Under Curve; Bone and Bones; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Drug Tolerance; Economics, Pharmaceutical; Female; Half-Life; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Male; Neoplasms; Randomized Controlled Trials as Topic; Zoledronic Acid	2004
Safety and convenience of a 15-minute infusion of zoledronic acid. The oncologist, 2004, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2004
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses. Oncology, 2005, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cost-Benefit Analysis; Diphosphonates; Drug Costs; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Multicenter Studies as Topic; Nerve Compression Syndromes; Pain; Spinal Cord Compression; United States; Zoledronic Acid	2005
Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman. Aging clinical and experimental research, 2005, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Bone Diseases, Metabolic; Cognition Disorders; Diphosphonates; Disease Progression; Diuretics; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Nervous System Diseases; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2005
[Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2005, Volume: 126, Issue:5 Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Cells, Cultured; Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Geranyltranstransferase; Humans; Hypercalcemia; Imidazoles; Neoplasms; Osteoclasts; Zoledronic Acid	2005
[Treatment of Paget's disease of bone: importance of the zoledronic acid]. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Diphosphonates; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Remission Induction; Treatment Outcome; Zoledronic Acid	2006
[Therapeutic agents for disorders of bone and calcium metabolism: Zoledronic acid]. Clinical calcium, 2007, Volume: 17, Issue:1 Topics: Bone Density; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Osteoporosis, Postmenopausal; Zoledronic Acid	2007
Clinical research update: zoledronate. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Animals; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Mice; Multiple Myeloma; Rats; Zoledronic Acid	1997
Current and future directions in medical therapy: hypercalcemia. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2000
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Adult; Aged; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Zoledronic Acid	2001
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Seminars in oncology, 2001, Volume: 28, Issue:2 Suppl 6 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Zoledronic Acid	2001
Zoledronic acid. Drugs, 2001, Volume: 61, Issue:6 Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Neoplasms; Zoledronic Acid	2001
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. La Revue de medecine interne, 2001, Volume: 22, Issue:7 Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematologic Neoplasms; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Prognosis; Recurrence; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2001
Advances in the biology and treatment of myeloma bone disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-15, Volume: 58 Suppl 3 Topics: Antineoplastic Agents; Bone Diseases; Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Zoledronic Acid	2001
Conventional treatment of hypercalcemia of malignancy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-15, Volume: 58 Suppl 3 Topics: Calcitonin; Clinical Protocols; Diphosphonates; Drug Costs; Fluid Therapy; Gallium; Humans; Hydrocortisone; Hypercalcemia; Imidazoles; Neoplasms; Nucleic Acid Synthesis Inhibitors; Plicamycin; Prednisone; Rehydration Solutions; Zoledronic Acid	2001
Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates. International journal of palliative nursing, 2001, Volume: 7, Issue:6 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pain; Zoledronic Acid	2001

Trials

9 trial(s) available for zoledronic acid and Milk-Alkali Syndrome

Article	Year
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Multiple Myeloma; Neoplasms; Proportional Hazards Models; Zoledronic Acid	2015
Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:2 Topics: Adolescent; Adult; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Young Adult; Zoledronic Acid	2011
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Egypt; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Pain; Placebo Effect; Prospective Studies; Risk Assessment; Risk Factors; Spinal Cord Compression; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid	2010
Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdom. Clinical therapeutics, 2011, Volume: 33, Issue:3 Topics: Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cost-Benefit Analysis; Diphosphonates; Europe; Fractures, Bone; Health Care Costs; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Middle Aged; Quality-Adjusted Life Years; Spinal Cord Compression; Zoledronic Acid	2011
Clinical significance of zoledronic acid and strontium-89 in patients with asymptomatic bone metastases from non-small-cell lung cancer. Clinical lung cancer, 2013, Volume: 14, Issue:3 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Spinal Cord Compression; Strontium; Zoledronic Acid	2013
A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Treatment Outcome; Zoledronic Acid	2005
[Use of zoledronic acid for high risk prostate cancer patients]. Der Urologe. Ausg. A, 2005, Volume: 44, Issue:2 Topics: Animals; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Europe; Humans; Hypercalcemia; Imidazoles; Injections, Intravenous; Male; Prostatic Neoplasms; Treatment Outcome; Zoledronic Acid	2005
A dose-finding study of zoledronate in hypercalcemic cancer patients. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999, Volume: 14, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Zoledronic Acid	1999
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Seminars in oncology, 2001, Volume: 28, Issue:2 Suppl 6 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Zoledronic Acid	2001

Other Studies

63 other study(ies) available for zoledronic acid and Milk-Alkali Syndrome

Article	Year
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17 Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid	2002
Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia. Kidney international, 2022, Volume: 101, Issue:5 Topics: Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Pamidronate; Zoledronic Acid	2022
Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab. Journal of pediatric endocrinology & metabolism : JPEM, 2022, Aug-26, Volume: 35, Issue:8 Topics: Adolescent; Bone Density Conservation Agents; Calcium; Child; Denosumab; Diphosphonates; Hormones, Ectopic; Humans; Hypercalcemia; Male; Parathyroid Hormone; Rhabdomyosarcoma; Zoledronic Acid	2022
Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs. Australian veterinary journal, 2023, Volume: 101, Issue:1-2 Topics: Animals; Calcium; Dog Diseases; Dogs; Hypercalcemia; Neoplasms; Pain; Palliative Care; Retrospective Studies; Zoledronic Acid	2023
Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI. Calcified tissue international, 2023, Volume: 112, Issue:5 Topics: Bone Density; Bone Density Conservation Agents; Calcium; Child; Denosumab; Humans; Hypercalcemia; Male; Osteogenesis Imperfecta; Zoledronic Acid	2023
Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report. BMC endocrine disorders, 2023, Jun-16, Volume: 23, Issue:1 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Zoledronic Acid	2023
Successful treatment of hypercalcemia in a Chinese patient with a novel homozygous mutation in the CYP24A1 gene using zoledronic acid: a case report. Journal of pediatric endocrinology & metabolism : JPEM, 2023, Sep-26, Volume: 36, Issue:9 Topics: Calcium; East Asian People; Female; Humans; Hypercalcemia; Infant; Mutation; Vitamin D3 24-Hydroxylase; Zoledronic Acid	2023
Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab. Endocrine journal, 2020, Jan-28, Volume: 67, Issue:1 Topics: Ankle; Anorexia; Antithyroid Agents; Aromatase Inhibitors; Arthralgia; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Collagen Type I; Denosumab; Deprescriptions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Graves Disease; Humans; Hypercalcemia; Methimazole; Middle Aged; Parathyroid Hormone; Peptides; Potassium Iodide; Radionuclide Imaging; Tartrate-Resistant Acid Phosphatase; Thirst; Zoledronic Acid	2020
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:8 Topics: Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cohort Studies; Denosumab; Female; Humans; Hypercalcemia; Hypocalcemia; Incidence; Male; Middle Aged; Retrospective Studies; Zoledronic Acid	2019
Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum. Journal of pediatric endocrinology & metabolism : JPEM, 2019, Dec-18, Volume: 32, Issue:12 Topics: Bone Density Conservation Agents; Calcitriol; Carcinoma, Squamous Cell; Child, Preschool; Humans; Hypercalcemia; Male; Paraneoplastic Syndromes; Prognosis; Xeroderma Pigmentosum; Zoledronic Acid	2019
Hypercalcemia of Malignancy in a Patient with Hypoparathyroidism: A Complicated but Treatable Condition. Puerto Rico health sciences journal, 2019, Volume: 38, Issue:4 Topics: Bone Density Conservation Agents; Calcitriol; Diphosphonates; Eye Neoplasms; Humans; Hypercalcemia; Hypoparathyroidism; Male; Melanoma; Middle Aged; Noonan Syndrome; Zoledronic Acid	2019
Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Denosumab; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Spinal Cord Compression; Zoledronic Acid	2021
Parathyroid Hormone-Related Peptide (PTHrp)-Secreting Liver Metastatic Large-Cell Neuroendocrine Carcinoma of the Sigmoid Colon. The American journal of medicine, 2021, Volume: 134, Issue:9 Topics: Aged; Biopsy; Bone Density Conservation Agents; Carcinoma, Neuroendocrine; Colon, Sigmoid; Colonic Neoplasms; Colonoscopy; Humans; Hypercalcemia; Liver Neoplasms; Male; Neoplasm Grading; Neoplasm Staging; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2021
Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia. Archives of osteoporosis, 2017, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Middle Aged; Sarcoidosis; Zoledronic Acid	2017
Immobilization-induced severe hypercalcaemia successfully treated with reduced dose of zoledronate in a maintenance haemodialysis patient. Nephrology (Carlton, Vic.), 2018, Volume: 23, Issue:10 Topics: Adult; Bed Rest; Bedridden Persons; Biomarkers; Bone Density Conservation Agents; Calcium; Humans; Hypercalcemia; Male; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Up-Regulation; Zoledronic Acid	2018
What is causing this patient's hypercalcemia? JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:5 Topics: Abdominal Pain; Diagnosis, Differential; Fatal Outcome; Female; Humans; Hypercalcemia; Middle Aged; Neoplasms, Unknown Primary; Psychotherapy, Brief; Sodium Chloride; Tomography, X-Ray Computed; Zoledronic Acid	2019
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia. American journal of perinatology, 2019, Volume: 36, Issue:S 02 Topics: Bone Density Conservation Agents; Calcium; Drug Resistance; Fat Necrosis; Female; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Methylprednisolone; Sodium Potassium Chloride Symporter Inhibitors; Subcutaneous Fat; Term Birth; Zoledronic Acid	2019
Mismanagement of malignant hypercalcaemia. Clinical medicine (London, England), 2013, Volume: 13, Issue:1 Topics: Bone Density Conservation Agents; Calcium; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Malpractice; Neoplasms; Zoledronic Acid	2013
Longest survival of lung metastatic ameloblastoma with a rare cause of malignant hypercalcemia. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:4 Topics: Ameloblastoma; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Male; Mandibular Neoplasms; Middle Aged; Polydipsia; Polyuria; Treatment Refusal; Zoledronic Acid	2014
Livedo reticularis heralding hypercalcaemia of malignancy. BMJ case reports, 2014, May-15, Volume: 2014 Topics: Calcitonin; Carcinoma, Squamous Cell; Diphosphonates; Diuretics; Fluid Therapy; Follow-Up Studies; Humans; Hypercalcemia; Imidazoles; Livedo Reticularis; Male; Middle Aged; Monitoring, Physiologic; Mouth Neoplasms; Risk Assessment; Treatment Outcome; Zoledronic Acid	2014
Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion. Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:6 Topics: Bone Density Conservation Agents; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Parathyroid Hormone; Pelvis; Penile Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Zoledronic Acid	2014
Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia. Acta clinica Belgica, 2015, Volume: 70, Issue:3 Topics: Aged; Bone Density Conservation Agents; Calcitonin; Chemokines; Cytokines; Diphosphonates; Diuretics; Female; Furosemide; Humans; Hypercalcemia; Imidazoles; Lymphoma, Follicular; Neoplasm Staging; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parotid Gland; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Sodium Chloride; Vitamin D; Zoledronic Acid	2015
Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Cancer investigation, 2015, Volume: 33, Issue:8 Topics: Aged; Bone Neoplasms; Calcitonin; Diphosphonates; Diuretics; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pamidronate; Quality of Health Care; Treatment Outcome; Zoledronic Acid	2015
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11 Topics: Acute-Phase Reaction; Adolescent; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Diseases; Calcitriol; Calcium; Child; Child, Preschool; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Osteoporosis; Prospective Studies; Retrospective Studies; Risk Factors; Young Adult; Zoledronic Acid	2015
Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation. BMJ case reports, 2015, Oct-13, Volume: 2015 Topics: Aged, 80 and over; Bone Density Conservation Agents; Brugada Syndrome; Cardiac Conduction System Disease; Diagnosis, Differential; Diphosphonates; Diuretics; Echocardiography; Electrocardiography; Follow-Up Studies; Furosemide; Humans; Hypercalcemia; Imidazoles; Male; Multiple Myeloma; Myocardial Ischemia; Point-of-Care Testing; Treatment Outcome; Zoledronic Acid	2015
A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration. Journal of pharmacy practice, 2016, Volume: 29, Issue:2 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Hypophosphatemia; Imidazoles; Male; Middle Aged; Paraneoplastic Syndromes; Zoledronic Acid	2016
Dual antiplasmodial activity of vitamin D3 and its analog, 22-oxacalcitriol, by direct and indirect mechanisms. Parasitology international, 2017, Volume: 66, Issue:2 Topics: Acute Disease; Animals; Antimalarials; Body Weight; Calcitriol; Cholecalciferol; Chronic Disease; Diphosphonates; Erythrocytes; Humans; Hypercalcemia; Imidazoles; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Knockout; Parasitemia; Plasmodium chabaudi; Receptors, Calcitriol; Zoledronic Acid	2017
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid. European journal of clinical pharmacology, 2008, Volume: 64, Issue:10 Topics: Adult; Antineoplastic Agents; Diphosphonates; Drug Interactions; Drug Therapy, Combination; Humans; Hypercalcemia; Imidazoles; Itraconazole; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin; Zoledronic Acid	2008
A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:9 Topics: Aged; Algorithms; Bone Density Conservation Agents; Calcitonin; Carcinoma, Transitional Cell; Crystalloid Solutions; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Isotonic Solutions; Male; Neoplasm Metastasis; Pamidronate; Ureteral Neoplasms; Zoledronic Acid	2009
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
FDA drug information that never reaches clinicians. The New England journal of medicine, 2010, Feb-11, Volume: 362, Issue:6 Topics: Diphosphonates; Drug Approval; Drug Industry; Drug Labeling; Humans; Hypercalcemia; Imidazoles; Kidney Diseases; United States; United States Food and Drug Administration; Zoledronic Acid	2010
[Primary hyperparathyroidism in a patient with Paget's bone disease]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:4 Topics: Adenoma; Aged; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Osteitis Deformans; Osteoporosis; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Zoledronic Acid	2010
[A case report of a patient treatable by home palliative care, administered zoledronic acid used for bladder cancer with hypercalcemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:5 Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Fatal Outcome; Female; Home Care Services; Humans; Hypercalcemia; Imidazoles; Palliative Care; Terminal Care; Urinary Bladder Neoplasms; Zoledronic Acid	2010
[Parathyroid crisis due to a cystic parathyroid adenoma]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:3 Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases; Consciousness Disorders; Cysts; Diagnostic Imaging; Diphosphonates; Emergencies; Female; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Intestinal Perforation; Kidney Calculi; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Thyroidectomy; Zoledronic Acid	2011
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:5 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Diphosphonates; Female; Fluorouracil; Humans; Hypercalcemia; Imidazoles; Leucovorin; Middle Aged; Neoplasm Recurrence, Local; Treatment Failure; Vinblastine; Vinorelbine; Zoledronic Acid	2011
Small cell carcinoma of the urinary bladder with hypercalcemia. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Small Cell; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid	2012
A case of acquired Fanconi syndrome induced by zoledronic acid. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Fanconi Syndrome; Female; Humans; Hypercalcemia; Imidazoles; Kidney Function Tests; Middle Aged; Zoledronic Acid	2011
Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma. Clinical lymphoma, myeloma & leukemia, 2011, Volume: 11, Issue:4 Topics: Aged; Bone Density Conservation Agents; Bone Diseases; Bone Diseases, Metabolic; Comorbidity; Diphosphonates; Drug Administration Schedule; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Proportional Hazards Models; Retrospective Studies; Spinal Cord Compression; Zoledronic Acid	2011
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan. Journal of medical economics, 2012, Volume: 15, Issue:1 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Diphosphonates; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Insurance Claim Review; Medicare Part C; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Spinal Cord Compression; United States; Zoledronic Acid	2012
Denosumab for the treatment of bisphosphonate-refractory hypercalcemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-10, Volume: 30, Issue:29 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Carcinoma, Renal Cell; Denosumab; Diphosphonates; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Parathyroid Hormone; Risk Assessment; Zoledronic Acid	2012
Impact of chemotherapy on hypercalcemia in breast and lung cancer patients. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Deoxycytidine; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Hypercalcemia; Imidazoles; Linear Models; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pamidronate; Parathyroid Hormone-Related Protein; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Taxoids; Young Adult; Zoledronic Acid	2012
Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Cancer Care Facilities; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Middle Aged; Pamidronate; Registries; Retrospective Studies; Spinal Cord Compression; Zoledronic Acid	2013
Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ (Clinical research ed.), 2004, Feb-07, Volume: 328, Issue:7435 Topics: Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Zoledronic Acid	2004
Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:9 Topics: Bone Resorption; Breast Neoplasms; Diphosphonates; Drug Resistance; Female; Humans; Hypercalcemia; Imidazoles; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Pamidronate; Quality of Life; Recurrence; Zoledronic Acid	2004
Hypocalcaemia after intravenous bisphosphonate: read the product information first. BMJ (Clinical research ed.), 2004, Jun-12, Volume: 328, Issue:7453 Topics: Diphosphonates; Drug Labeling; Humans; Hypercalcemia; Hypocalcemia; Imidazoles; Infusions, Intravenous; Zoledronic Acid	2004
Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid. The oncologist, 2005, Volume: 10, Issue:1 Topics: Bone Neoplasms; Creatinine; Diphosphonates; Half-Life; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Kidney; Safety; Zoledronic Acid	2005
The issue of renal safety of zoledronic acid from a nephrologist's point of view. The oncologist, 2005, Volume: 10, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2005
"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe. The oncologist, 2005, Volume: 10, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2005
Osteonecrosis of the jaws and bisphosphonates. Report of three cases. Medicina oral, patologia oral y cirugia bucal, 2006, Jan-01, Volume: 11, Issue:1 Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Tooth Extraction; Zoledronic Acid	2006
[Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Safety; Zoledronic Acid	2005
[Two cases of stage IV breast cancer with severe hypercalcemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Goserelin; Humans; Hypercalcemia; Imidazoles; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Quality of Life; Tamoxifen; Zoledronic Acid	2006
Bisphosphonate-associated arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2006, Volume: 12, Issue:3 Topics: Arthritis; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Middle Aged; Pamidronate; Zoledronic Acid	2006
Potential effect of zoledronate therapy in heavy proteinuria. Clinical nephrology, 2007, Volume: 67, Issue:4 Topics: Biopsy; Bone Density Conservation Agents; Diphosphonates; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Middle Aged; Multiple Myeloma; Prednisone; Proteinuria; Zoledronic Acid	2007
Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. Journal of immunology (Baltimore, Md. : 1950), 2007, Jul-01, Volume: 179, Issue:1 Topics: Animals; Bone Resorption; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Immunologic; Female; Hydroxycholecalciferols; Hypercalcemia; Imidazoles; Immunity, Innate; Immunoglobulin G; Influenza A Virus, H3N2 Subtype; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Fusion Proteins; Zoledronic Acid	2007
Role of the nurse in preserving patients' independence. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2007, Volume: 11 Suppl 2 Topics: Activities of Daily Living; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Documentation; Drug Monitoring; Humans; Hypercalcemia; Imidazoles; Nurse's Role; Nursing Assessment; Nursing Records; Oncology Nursing; Pain; Patient Compliance; Patient Education as Topic; Social Support; Treatment Outcome; Zoledronic Acid	2007
Acute adrenal crisis and hypercalcemia in a patient assuming high liquorice doses. Minerva medica, 2008, Volume: 99, Issue:1 Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Alkalosis; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Female; Glycyrrhiza; Humans; Hydrocortisone; Hyperaldosteronism; Hypercalcemia; Hypernatremia; Hypokalemia; Imidazoles; Middle Aged; Zoledronic Acid	2008
Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:5 Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Drug Evaluation, Preclinical; Hypercalcemia; Imidazoles; Interleukin-1; Male; Mice; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parathyroidectomy; Peptide Fragments; Proteins; Rats; Thyroidectomy; Zoledronic Acid	1994
Pamidronate (Aredia) and zoledronate: update on clinical results. Introduction. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Organophosphorus Compounds; Osteoblasts; Pamidronate; Zoledronic Acid	1996
Zoledronate. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteitis Deformans; Osteoporosis; Zoledronic Acid	1996
Zoledronate: the preclinical pharmacology. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Animals; Bone Resorption; Cholecalciferol; Depression, Chemical; Diphosphonates; Disease Models, Animal; Female; Hypercalcemia; Imidazoles; Ovariectomy; Pamidronate; Parathyroidectomy; Rats; Thyroidectomy; Zoledronic Acid	1996
Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM). Breast cancer (Tokyo, Japan), 2000, Volume: 7, Issue:4 Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Osteoclasts; Osteoporosis; Pamidronate; Prostatic Neoplasms; Zoledronic Acid	2000
From the Food and Drug Administration. JAMA, 2001, Oct-03, Volume: 286, Issue:13 Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Diphosphonates; Equipment Reuse; Heart Failure; Humans; Hypercalcemia; Imidazoles; Natriuretic Peptide, Brain; Neoplasms; United States; United States Food and Drug Administration; Zoledronic Acid	2001
New bisphosphonic acid approved by FDA. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Oct-01, Volume: 58, Issue:19 Topics: Diphosphonates; Drug Approval; Humans; Hypercalcemia; Imidazoles; Neoplasm Proteins; Neoplasms; Parathyroid Hormone-Related Protein; United States; United States Food and Drug Administration; Zoledronic Acid	2001